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ABSTRAKS (VERSI BAHASA MELAYU) 
Latar belakang 
Jangkitan  paru-paru perolehan komuniti (CAP) merupakan penyakit yang biasa dan 
sebanyak 20-40% pesakit ini memerlukan rawatan lanjut. Ia juga mempunyai kadar 
morbiditi dan kematian yang tinggi.CAP masih lagi menjadi salah satu punca utama 
kematian daripada penyakit berjangkit. Terdapat beberapa ujian yang telah 
dikemaskini untuk mengukur keterukan penyakit, meramal kematian pesakit dan 
sebagai panduan keputusan klinikal mengenai tahap intervensi yang diperlukan untuk 
pemantauan yang lebih baik.  
Tujuan kajian ini adalah untuk mengenalpasti kebolehan prognostikasi CURB-65 
dalam meramal kebarangkalian untuk mendapat komplikasi di kalangan pesakit yang 
dirawat di wad.  
Kaedah Kajian  
Kajian ini merupakan kajian pemerhatian kohort retrospektif yang dijalankan ke atas 
pesakit yang dimasukkan ke wad perubatan dan unit rawatan rapi HUSM yang 
memenuhi kriteria-kriteria yang telah ditetapkan, bermula Jun 2012 hingga Mei 2014. 
Profil pesakit dan penyakit jangkitan paru-paru dilihat dalam kajian deskripsi. 
Komplikasi yang dikaji dalam kajian ini adalah penggunaan bantuan inotropik, 
keperluan untuk bantuan ventilasi, kemasukan ke unit rawatan rapi dan kematian di 
hospital. Kebolehan prognostikasi CURB-65 dalam menjangkakan komplikasi-
komplikasi tersebut dianalisis mengunakan 4 ujian iaitu Ujian Chi-Squre, SLR, 
analysis lengkuk ROC, sensitiviti, spesifisiti dan nilai kebolehan negatif dan positif. 
Nilai yang diletakkan untuk menandakan CURB-65 tinggi adalah 3 hingga 5.  
xv 
 
Keputusan 
Majoriti pesakit merupakan Melayu (95.4%) dengan agihan yang hampir bagi lelaki 
dan perempuan dan min usia adalah 63.29 (SD+16.55) tahun. Presentasi utama 
pesakit adalah demam, diikuti oleh batuk berkahak. Kadar kematian di hospital 
adalah 8.8%, penggunaan bantuan inotropik ialah 11.1%, keperluan untuk bantuan 
ventilasi ialah 12.6% dan kemasukan ke unit rawatan rapi ialah 6.9%. Skor CURB-65 
menunjukkan sensitiviti (89-100%), specifisiti (84-88%), nilai kebolehan negatif dan 
kawasan bawah lengkuk ROC yang tinggi serta mempunyai hubungan yang 
signifikan dengan semua komplikasi. Ia juga mempunyai nilai diskriminasi yang 
bagus ke cemerlang (0.853-0.938). 
Kesimpulan 
Kajian kami menunjukan  CURB-65 mempunyai kebolehan prognostikasi dalam 
menjangkakan komplikasi seperti penggunaan bantuan inotropik, keperluan untuk 
bantuan ventilasi, kemasukan ke unit rawatan rapi dan kematian di hospital di 
kalangan pesakit yang dimasukkan ke wad untuk jangkitan paru-paru dengan nilai 
sensitiviti dan specifisiti yang tinggi. 
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ABSTRACT (ENGLISH VERSION) 
Background 
Community Acquired pneumonia (CAP)  is a common disease and many patients 
require admission, which is about 20-40% of patients. It also has high morbidity and 
mortality. CAP still remains one of the leading causes of death from  infectious 
diseases. There are several validated tools to assess severity, predict mortality in 
patients admitted with CAP and guide clinical decision about the level of intervention 
required for better monitoring and treatment. 
The purpose of this study is to determine the prognostic ability of CURB-65 as a 
pneumonia severity score in predicting outcomes in hospitalized patients with CAP.  
Methodology 
The study was an observational retrospective cohort study performed for patients 
admitted to medical ward and intensive care unit (ICU) HUSM that fulfilled 
diagnosis for CAP, from June 2012 till May 2014. The clinical profiles for CAP in 
HUSM were elaborated in a descriptive study. The adverse outcomes that were 
investigated in this study were use of inotropic support, need of ventilation support, 
ICU admission and in hospital mortality. The prognostic ability of CURB-65 in 
predicting outcomes were analysed using 4 tests, i.e: Chi square test, SLR, ROC 
curve analysis and sensitivity, specificity and predictive values. The recommended 
cut off points to indicate higher CURB-65 score was 3 to 5.  
Results 
The majority of patients were Malay (95.4%) with almost equal male to female 
distribution and mean age of 63.29 (SD+16.55) years. The proportion of in hospital 
xvii 
 
mortality was 8.8%, use of inotropic support was 11.1% , need of ventilation support 
was 12.6% and need of ICU admission was 6.9%. CURB-65 score severity category 
demonstrated high sensitivity (89-100%), specificity (84-88%), negative predictive 
value (99-100%) and area under ROC curve; and significant association with all the 
adverse outcomes. It also had good to excellent discriminative values (0.853-0.938). 
Conclusion 
Our study showed CURB-65 had a prognostic ability in predicting outcomes i.e: used 
of inotropic support, need of ventilation support, need of ICU admission and 
inhospital mortality for hospitalised patients with community acquired pneumonia 
with high sensitivity and specificity. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Study Background  
Community acquired pneumonia (CAP) is a common disease, in which about 15-50% 
of these patients require admission, and about 5-10% of those admitted patients 
require management in an intensive care unit (ICU) (Hoare et al, 2006; Hoogewerf M 
et al, 2006). It also has  high morbidity and mortality (Andrew J et al, 2003). CAP 
still remains one of the leading causes of death from infectious diseases worldwide 
(Ramirez JA, 2003; Song JH et al, 2009). 
This disease inevitably imposes a heavy burden on the healthcare system in terms of 
its high cost both for diagnosing and managing the disease, whether for ward or ICU 
admission, (Moran GJ et al, 2009; Xu F et al, 2008) in which, pointing out the 
importance of predicting the need for hospitalization, whether to ICU or general 
medical ward, as well as the outcome of the patient during treatment course (Lim 
WS, 2003). 
The British Thoracic Society (BTS) (Macfarlane JT et al, 2001), Infectious Diseases 
Society of America (Bartlett JG et al, 2000) and the Canadian Thoracic Society 
(Mandell LA et al, 2000) guidelines recommend the use of validated prognostic tools 
on admission to hospital as adjuncts to clinical judgement in managing CAP (Fine MJ 
et al, 1997; Lim WS et al, 2003). It is important to assess the severity of pneumonia, 
particularly on presentation as this can be used to guide physician in treatment plan, 
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further intervention and level of care, as well as allow predictions about progression 
of the disease and prognosis (Carol P et al, 2008). 
There are several validated tools or scoring system to assess severity, predict 
mortality in patients admitted with CAP and guide clinical decision about the level of 
intervention required (Macfarlane JT et al, 2001; Bartlett JG et al, 2000; Mandell LA 
et al, 2000; American Thoracic Society, 2001). 
These severity scoring systems were developed to improve the efficiency and 
effectiveness of health care. The ability of prediction tools to assess outcome of CAP 
helps physicians in identifying high risk patients for better monitoring and treatment 
as well as to prevent adverse outcome. 
Internationally, several guidelines currently recommend the use of the Pneumonia 
Severity Index developed by Fine et al and / or the CURB-65 score developed by Lim 
and colleague as severity scoring tools. (BTS Standards of Care Committee, 2001; 
Mandell LA et al, 2007) 
The purpose of this study is to determine the ability of CURB-65 as a pneumonia 
severity score in predicting outcomes in hospitalized patient with CAP.  
Although many studies reported that severity scoring system helps clinicians in 
managing patients with CAP, this scoring system is still not aggressively used in our 
population. Hopefully this study can convince clinicians that a simple scoring system 
which is CURB-65 is applicable and useful in predicting outcomes of CAP, 
especially need of ventilator support, need of inotropic support, need of ICU 
admission and mortality. 
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The accuracy of the CURB-65 score is now well established but it has not been 
universally accepted. Although simpler than the PSI, still large majority doctors were 
unable to name its components properly. 
Despite increasing publicity and programme to promote severity assessment, a few 
studies showed that only 13% of patients received severity assessment on admission 
(Collini P et al, 2007; James D Chalmers et al, 2008). The study in United Kingdom 
by Barlow GD et al (2003) showed that junior doctors have poor awareness of the 
BTS recommendations. In a survey of 83 junior and middle grade doctors, only 4% 
could correctly state all four prognostic markers of the BTS CURB tool. 
The clinical application of severity tools has been described as dependent on three 
factors: 1) the accurate prediction of the outcome of interest; 2) the ability to classify 
patients into clinically useful groups (e.g by level of risk); 3) simplicity. (Chalmers 
JD et al, 2012; Relly BM et al, 2006) All these criterias are fulfilled by the CURB-65 
severity score. 
Additionally, the basic information required to determine the CURB-65, are routinely 
documented in medical record at the initial hospital assessment, four of the five 
required criteria are assessable clinically and fifth (blood urea) is a simple laboratory 
test available even in low technology setting, making it possible to generate a 
prediction rule for each patient at the point of care, before determining further active 
intervention. 
The severity scoring could be used along with clinical judgement in therapeutic 
decision making. It is necessary to promptly identify high risk patients to aid 
therapeutic decision making, and guide prognosis. Therefore, the data collected in 
this   study  will   justify  the  need  and  usefulness  of severity  scoring  system for  
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community acquired pneumonia and at the same time guide us for further aggressive 
intervention for high risk patients. In addition, this score is easy to apply in day-to-
day clinical practice. 
 
1.2 Epidemiology Of Community Acquired Pneumonia 
Pneumonia is one of the commonest causes of admission to the hospital especially in 
medical ward with lifetime prevalence of 20-30% in developing countries and 3-4% 
in developed countries (Shah BA et al, 2010). 
It is associated with significant adverse outcomes and complications including 
mortality. (Feagan BG et al, 2000; Fine JM et al, 1999; Lim WS et al, 2000). The 
disease imposes a major burden on the healthcare resources in terms of its high cost 
both for diagnosing and managing the disease (Moran GJ et al, 2009; Mandell LA et 
al, 2007). 
In view of the clinical importance of CAP, many countries have developed national 
guidelines for the management of this condition (Task force on CAP, 1998; 
Heffelfinger JD et al, 2000; Bartlett JG et al, 2000; Mandell LA et al, 2003; Mandell 
LA et al, 2000; Niederman MS et al, 2001; British Thoracic Society, 2001). By the 
way, the most widely used guideline is the BTS Guideline for Management of CAP 
2009. 
Pneumonia is also a common cause of death among hospital admissions. Pneumonia 
was ranked the 6th main cause of death for patients hospitalized in Penang 
government hospitals in year 2005 (Hooi LN et al, 2001) and it remains the leading 
cause of death in many developed and developing countries. It is the 7th leading cause 
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of death in the United States in 2000, after heart disease, malignant neoplasm, 
cerebrovascular disease, chronic lower respiratory tract disease, unintentional injuries 
and diabetes mellitus. 
According to Malaysia Ministry of Health Annual Report 2012, the second principal 
cause of hospitalization in Ministry of Health hospitals in 2012 is disease of 
respiratory system including community acquired pneumonia. It accounts for 11.02% 
of total admissions. Disease of respiratory system is also the second principal cause 
of death in Ministry of Health hospitals in 2011 (18.80%), after disease of the 
circulatory system (24.69%). (Annual Report Ministry of Health 2012). 
Severity assessment and site-of-care decisions for patients with CAP are pivotal for 
patients’ safety and adequate allocation of resources. 
A retrospective study by Shaharudin and colleagues (2011) from Hospital Universiti 
Sains Malaysia (HUSM) in 2004, from one hundred and fifty-five patients 
hospitalized with CAP, the inpatient mortality was 19.4%. Loh et al (2001) reported a 
12% mortality rate in 2001 in Seremban Hospital while Liam et al (2000), at the 
University Malaya Medical Centre (UMMC) reported a mortality of 13.7% in 2000.  
In the United Kingdom, death from CAP has been reported to be 5.7% to 12% (BTS, 
2001), while a meta-analysis by Fine and colleagues (1996) showed a 13.6% 
mortality rate in hospitalized patients to 36.5% mortality rate for patients admitted to 
intensive care unit (ICU).  
It is now recognized that prognosis significantly depends on early treatment taken in 
approaching this disease. Due to the high rate of mortality among patients with CAP, 
there is a need for an accurate predictive tool for the physicians to make the decisions 
on appropriate therapy.  
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There are several validated tools to assess severity and predict mortality in patients 
admitted with CAP. These severity scoring systems are developed to improve the 
efficiency and effectiveness of health care. The ability of a prediction tool to assess 
mortality of CAP helps physicians in identifying high risk patients for better 
monitoring and treatment. 
 
1.3 Definition of Pneumonia 
Pneumonia is defined as an infection of the lungs involving alveoli, distal airways 
and interstitium of the lung. The infection is manifested by replacement of the normal 
lung sponginess by consolidation. The alveoli also filled with red blood cells, white 
blood cells and fibrin.  
Infectious Disease Society of America (IDSA) defined pneumonia as an acute 
infection of the lung parenchyma accompanied by acute infiltrates on chest 
radiograph or an auscultatory finding consistent with pneumonia which are presence 
of altered breath sounds and / or localized rales, with two of the following: fever or 
hypothermia, rigors, sweating, new cough with or without sputum or change in color 
of respiratory secretions in a patient with chronic cough, chest discomfort and 
dyspnea. In the elderly, it is more common to be afebrile or hypothermic. In elderly 
also, sometimes altered mental status is the only complaint. 
 
1.4 Classification of Pneumonias 
Pneumonia can be divided into several different classifications depending on clinical 
characteristics, source of infection, aetiological factors or morphological factors.  
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Based on source of infection, pneumonia can be divided into: 
1) Community-acquired pneumonia (CAP). It is defined as an acute infection of the 
pulmonary parenchyma in a patient who has acquired the infection in the 
community. The common organism for this pneumonia will be elaborated on in 
the part on aetiology. 
2) Hospital-acquired pneumonia (HAP) or Nosocomial pneumonia. This is a 
respiratory infection that begins in a nonintubated patient after 48 hours of 
admission or within 90 days of admission. 
3) Healthcare associated pneumonia (HCAP). It is defined as a respiratory infection 
that occurs: 
• within 90 days of a hospitalization that lasts 2 days or more, or 
• in a patient that stays at a nursing home, or 
• in a patient that has a visit to an intravenous puncture care facility or a 
hospital-based clinic or hemodialysis facility, or  
• within 3 days of receiving antibiotics, chemotherapy, or any type of wound 
care. 
4) Ventilator associated pneumonia (VAP). This is a nosocomial pneumonia that 
begins more than 48 hours after the patient is intubated. 
5) Aspiration pneumonia. Aspiration pneumonia is broadly deﬁned as the pulmonary 
sequelae of abnormal entry of material from the stomach or upper respiratory tract 
into the lower airways. The term generally applies to large-volume aspiration. 
There are at least 3 distinctive forms, based on the nature of the inoculum, the 
clinical presentation, and management guidelines: toxic injury of the lung (such 
as due to gastric acid aspiration or Mendelson’s syndrome), obstruction (with a 
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foreign body or ﬂuids), or infection. (Barlett JG et al, 1975; Barlett JG et al, 1993; 
Matthay MA et al, 1996). 
6) Pneumonia in the immunocompromised host or opportunistic pneumonia. This 
group includes patients on chemotherapy, on immunosuppressant treatment such 
as high dose steroid or retroviral disease. Main pathogens are cytomegalovirus, 
Pneumocystis jiroveci, Mycobacterium avium-intracellulare, invasive 
aspergillosis and invasive candidiasis.  
Pneumonia also can be classified by clinical characteristics. This divides them into 
acute (less than three weeks duration) and chronic pneumonias. Acute pneumonias 
are further divided into the classic bacterial bronchopneumonias (such 
as Streptococcus pneumoniae), the atypical pneumonias (such as the interstitial 
pneumonitis of Mycoplasma pneumoniae or Chlamydia pneumoniae). Chronic 
pneumonias tend to be either non-infectious, mycobacterial, fungal, or mixed 
bacterial infections caused by airway obstruction. The most common cause of chronic 
pneumonias  include Nocardia, Actinomyces and Blastomyces dermatitidis, as well as 
the granulomatous pneumonias (Mycobacterium tuberculosis and atypical 
mycobacteria, Histoplasma capsulatum and Coccidioides immitis). 
With the advent of modern microbiology, classification based upon the causative 
microorganism become possible. Determining which microorganism is causing an 
individual's pneumonia is an important step in deciding treatment type and length. 
Other than that, pneumonia also can be classified based on anatomical or 
morphological type. It can be classified as lobar pneumonia (infection that only 
involves a single lobe of a lung). Lobar pneumonia is often due to Streptococcus 
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pneumoniae (though Klebsiella pneumoniae is also possible). Multilobar pneumonia 
involves more than one lobe, and it often causes a more severe illness. 
 
1.5 Aetiology Of Community Acquired Pneumonia (CAP) 
Although many microorganisms have been associated with CAP, it is a small range of 
key pathogens that cause most cases that can be identified. Streptococcus pneumoniae 
(pneumococcus) is the most frequently identified pathogen, with the highest 
incidence of this organism reported in studies that used urinary antigen detection. 
Apart from Streptococcus pneumoniae, a great deal of literature in Western countries 
have reported Haemophilus influenza; atypical pathogens such as Chlamydia 
pneumoniae, Mycoplasma pneumonia and Legionella pneumophila; and viruses 
(influenza virus, adenovirus, respiratory syncytial virus, parainfluenza virus and 
coronavirus) as common pathogens of CAP (Bartlett JG et al, 2000; British Thoracic 
Society, 2001; Jokinen C et al, 2001; Dowell SP et al, 1996; Marx A et al, 1999; 
Peiris JSM, 2003). 
Gram-negative bacilli (Enterobacteriaceae and pseudomonas) are the common cause 
of CAP in patients who have had previous antimicrobial treatment or who have 
pulmonary comorbidities such as chronic lung disease, lung fibrosis or chronic 
obstructive pulmonary disease (Aranclfla F et al, 2002). 
In one study, 33% of hospitalized CAP patients with unknown aetiology diagnosed 
by routine methods were found to be due to Streptococcus pneumoniae based on 
findings from transthoracic needle lung aspiration, suggesting that many patients 
without a known pathogen have pneumococcal infection (Ruiz-Gonzalez A et al, 
1999). 
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The microbial aetiological distribution of CAP reported in the literature depends on 
the patient population, the geographical region, the intensity of investigations carried 
out and the occurrence of epidemics of infection.  
Even when carefully sought for in large prospective studies, the putative causative 
organism remains unknown in about half of all patients with CAP. Reasons for failure 
to identify the aetiological agent include presence of fastidious organism, prior 
treatment with antibiotics, unusual pathogens that were unrecognized, viral 
infections, non-infectious mimic of CAP, and pathogens that are currently not 
identified or recognized. The differences in the microbiology of CAP as compared to 
what is reported in the West must be taken into consideration when selecting the 
appropriate antibiotics for initial empirical therapy of CAP in this region. 
A number of studies in Asia, where the prevalence of tuberculosis is high have shown 
that infection due to Mycobacterium tuberculosis may commonly present as an 
apparent CAP, which is about 4.8-15.3% of cases. (Chan CH et al, 1992; Hui KP et 
al, 1993; Hooi LN et al, 2001; Liam CK et al, 2003). Although pulmonary 
tuberculosis is a chronic respiratory infection, it can present as CAP and it should be 
a differential diagnosis in areas where tuberculosis is endemic. 
In studies conducted in Malaysia, 2 out of 127 (1.6%) patients in the Kuala Lumpur 
series had melioidosis, (Liam CK et al, 2001) while Burkholderia pseudomallei was 
not isolated in any patient in the Penang series (Hooi LN et al, 2001). Burkholderia 
pseudomallei should be considered a causative organism in patients with CAP in rural 
Southeast Asia particularly if the patient has diabetes mellitus. (Reechaipichitkul W 
et al, 2002). 
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From previous study in HUSM by Sanihah et al in 2007, only 38.5% from 142 
patients noted to have pathogen isolated. The most common organism isolated were 
Haemophilus influenza and Mycobacterium tuberculosis.  
Other than that, different centres have different common organisms. Different 
categories of pneumonia also have their own common pathogens. For example: 
a. Patients with  minimal comorbidities, S. pneumoniae, M. pneumoniae, C. 
pneumoniae and viruses. 
b. Patients with underlying chronic pulmonary or cardiovascular disease, most 
common pathogens are resistant S. pneumonia, H. Influenzae, M. Catarrhalis 
and Legionella pneumophila. 
c. Nosocomial patients (hospitalized or nursing home patient), most common 
pathogens are resistant gram negative rods, P. aeruginosa, methicillin 
resistant staph aureus and anaerobes (due to aspiration). 
d. Alcoholics patients, most common pathogens K. pneumoniae, anaerobes and 
tuberculosis. 
e. Intravenous drug users, most common pathogens are S. aureus, P. jerovoci 
and anaerobes. 
f. Post splenectomy patients, most common pathogens are S. pneumoniae and H. 
influenzae. 
g. HIV / AIDS patients, most common pathogens are P. jerovoci, S. 
pneumoniae, tuberculosis and fungal. 
h. Leukaemic or bone marrow transplant patients, most common pathogens are 
aspergillu fumigatuss, legionella pneumophila, cytomegalovirus and other 
fungal organisms. 
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i. Post influenza infection, most common pathogens are S. pneumoniae and S. 
aureus. 
j. Cystic fibrosis patients, most common pathogens are P. aeruginosa and S. 
aureus. 
k. Patients with animal exposure, most common pathogens are C. psittaci, C. 
neoformans, H. capsulatum (from exposure to birds); hantavirus (from 
exposure to rats); C. burnetti (from exposure to farm animals 
Table 1 shows the most common pathogens associated with CAP as derived from 
collective results of various studies conducted in the west and in the Asia Pacific 
region. (British Thoracic Society, 2001; Jokinen c et al, 2003; Aranclfla F et al, 
2002; Ruiz-Gonzalez A et al, 1999; Ishida T et al, 1998; Miyashita N et al, 2000; 
Woo JH et al, 2001; Chan CH et al, 1992; Reechaipichitkul W et al, 2002; 
Wattanathum A et al, 2003; Liam CK et al, 2001; Hooi LN et al, 2001; Liam CK 
et al, 2003; Hui KP et al, 1993; Ngeow YF et al, 2003; Luna CM et al, 2000; El 
Solh AA et al, 2001; Lee KH et al, 1996; Tan YK et al, 1998; Bochud PY et al, 
2001; Marrie TJ et al, 1996) 
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Table 1: Microbiological pattern of CAP in patients requiring hospitalization. 
Location No. of 
patients 
Frequency / rank of microbial cause (%) 
1 2 3 4 5 6 Unknown 
 
HUSM 
(Sanihah 
et al, 
2009) 
 
143 
 
 
(%) 
 
H. 
influen
zae 
6.3 
 
M. 
tubercul
osis 
6.3 
 
K. 
pneumon
iae 
4.9 
 
Candida  
Albicans 
 
3.5 
 
Streptococ
cal sp. 
 
2.8 
 
M. 
pneumoniae 
 
2.8 
 
 
 
 
61.5 
 
Kuala 
Lumpur 
(Liam CK 
et al, 2001) 
 
127 
 
 
 
(%) 
 
K. 
pneum
oniae 
 
10.2 
 
S. 
pneumoni
ae 
 
5.5 
 
H. 
influenza
e 
 
5.5 
 
M. 
pneumoni
ae 
 
3.9 
 
Ps. 
aeruginosa 
 
 
3.9 
 
Burkholderia
pseudomalle
i 
 
1.6 
 
 
 
 
 
58.3 
 
Penang 
(Hooi LN 
et al, 2001) 
 
1137 
 
 
(%) 
 
M. 
tubercu
losis 
15.3 
 
K. 
pneumoni
ae 
7.2 
 
Ps. 
aeruginos
a 
6.1 
 
S. aureus 
 
 
5.0 
 
S. 
pneumonia 
 
3.0 
 
Acinetobacte
r spp. 
 
3.0 
 
 
 
 
57.1 
 
Singapore 
(Hui KP et 
al, 1993) 
 
96 
 
 
(%) 
 
M. 
tubercu
losis 
21.0 
 
S. 
pneumoni
a 
12.0 
 
Gram 
negative 
bacilli  
10.0 
 
H. 
influenza
e 
5.2 
 
M. 
pneumonia
e 
5.2 
 
S. aureus 
 
 
4.2 
 
 
 
 
42.0 
 
United 
Kingdom 
(5 studies) 
(BTS, 
2001) 
 
1137 
 
 
 
(mean 
%) 
 
S. 
pneum
oniae 
 
 
39 
 
C. 
pneumoni
ae 
 
 
13.1 
 
M. 
pneumoni
ae 
 
 
10.8 
 
Influenza 
A & B 
 
 
 
10.7 
 
H. 
influenza 
 
 
 
5.2 
 
Legionella 
spp. 
 
 
 
3.6 
 
 
 
 
 
 
30.8 
 
Other part 
of Europe  
(23 
studies) 
(BTS, 
2001) 
 
6026 
 
 
 
(mean 
%) 
 
S. 
pneum
oniae 
 
 
19.4 
 
C. 
pneumoni
ae 
 
 
6.3 
 
M. 
pneumoni
ae 
 
 
6 
 
Influenza 
A & B 
 
 
 
5.3 
 
Legionella 
spp. 
 
 
 
5.1 
 
Gram 
negative 
enteric 
bacilli 
 
3.3 
 
 
 
  
 
 
 50.7 
 
Australia 
& New 
Zealand 
(3 studies) 
(BTS, 
2001) 
 
453 
 
 
 
 
(mean 
%) 
 
S. 
pneum
oniae 
 
 
 
38.4 
 
M. 
pneumoni
ae 
 
 
 
14.6 
 
H. 
influenza 
 
 
 
 
9.5 
 
Legionell
a spp. 
 
 
 
 
7.5 
 
Gram 
negative 
enteric 
bacilli 
 
 
4.6 
 
C. 
pneumonia 
 
 
 
 
3.1 
 
 
 
 
 
 
 
31.6 
 
North 
America  
(4 studies) 
(BTS, 
2001) 
 
1306 
 
 
 
(mean 
%) 
 
S. 
pneum
oniae 
 
 
11.3 
 
H. 
influenza 
 
 
 
6.3 
 
C. 
pneumoni
ae 
 
 
5.9 
 
Influenza 
A & B 
 
 
 
5.9 
 
Gram 
negative 
enteric 
bacilli 
 
5.3 
 
Legionella 
spp. 
 
 
 
4.3 
 
 
 
 
 
 
40.7 
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Table 2: Microbiological pattern of CAP in patients requiring hospitalization (cont.). 
Location No. of 
patients 
Frequency / rank of microbial cause (%) 
1 2 3 4 5 6 unknown 
 
Okayama 
(Ishida T 
et al, 1998) 
 
318 
 
 
(%) 
 
S. 
pneum
oniae 
23 
 
H. 
influenzae 
 
7.4 
 
M. 
pneumo
niae 
4.9 
 
K. 
pneumoni
ae 
4.3 
 
S. Milleri 
 
 
3.7 
 
C. 
pneumoniae 
 
3.4 
 
 
 
 
39 
 
Okayama 
(Miyashita 
N et al, 
2000) 
 
200 
 
 
(%) 
 
S. 
pneum
oniae 
20.5 
 
H. 
influenzae 
 
11.0 
 
M. 
pneumo
niae 
9.5 
 
C. 
pneumoni
ae 
7.5 
 
S. aureus 
 
 
5.0 
 
Anaerobs 
 
 
4.0 
 
 
 
 
41.5 
 
Korea  
(Woo JH 
et al, 2001) 
 
562 
 
 
(%) 
 
S. 
pneum
oniae 
21.7 
 
K. 
pneumonia
e 
14.8 
 
Ps 
aerugino
sa 
9.8 
 
S. aureus 
 
 
9.5 
 
Streptocco
cus 
Viridans 
5.7 
 
Enterobacter 
Cloacae 
 
4.2 
 
 
 
 
61.7 
 
Hong 
Kong  
(Chan CH 
et al, 1992) 
 
1137 
 
 
 
(%) 
 
M. 
Tuberc
ulosis 
 
12.0 
 
S. 
pneumonia 
 
 
12.0 
 
Chlamy
dia spp. 
 
 
6.0 
 
Viral 
 
 
 
6.0 
 
H. 
influenza 
 
 
4.0 
 
M. 
pneumonia 
 
 
3.0 
 
 
 
 
 
59.0 
 
Bangkok 
(Watanath
um A et al, 
2003) 
 
147 
 
 
 
(%) 
 
S. 
pneum
oniae 
 
22.4 
 
C. 
pneumonia
e 
 
16.3 
 
M. 
pneumo
niae 
 
9.5 
 
K. 
pneumoni
ae 
 
6.8 
 
L. 
pneumophi
la 
 
5.4  
 
H. influenza 
 
 
 
2.7 
 
 
 
 
 
29.0 
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1.6 Pathophysiology Of Community Acquired Pneumonia 
Pneumonia is an infectious process that occurs as a result of the invasion and 
overgrowth of microorganisms (as mentioned in aetiology part in this dissertation) in 
lung parenchyma, breaking down defense mechanisms. It further provokes intra-
alveolar exudate production. Basically, the development of pneumonia requires the 
pathogen to reach the alveoli and that host defenses were overwhelmed by 
microorganism virulence.   
The lungs are constantly exposed to particulate material and microbes that are present 
in the upper airway, from the air that is breathed in. The lower respiratory tract can be 
entered by microorganisms by several mechanisms which include gross aspiration or 
microaspiration of the oropharyngeal or gastric content, aerosolization of bacterial 
laden aerosol, haematogenous spread from a distant infected site and direct spread 
from a contiguous infected site. 
There are many determinant factors that can cause changes in the normal flora of the 
upper respiratory tract that predispose to infection, such as underlying disease, loss of 
mechanical respiratory defenses with the use of sedatives, tracheal intubation and 
antibiotic treatments.  
In pneumonia, lungs capillaries become leaky, and protein-rich fluid seeps into the 
alveoli. This can lead to a less functional area for oxygen-carbon dioxide exchange, 
causing relative oxygen deprivation, while retaining potentially damaging carbon 
dioxide. The alveoli fill further with fluid and debris from the large number of white 
blood cells that are being produced to fight the infection. Consolidation, a feature of 
bacterial pneumonias, occurs when the alveoli, which are normally hollow air spaces 
within the lung, instead become solid, due to fluid and debris. 
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Pathogenesis of pneumonia involves: 1) congestion, which occurs in day 1 of 
infection due to vasodilation of the capillaries, 2) red hepatisation, which occurs in 
day 2, with accumulation of red blood cells and exudative production, 3) grey 
hepatisation, which occurs on day 4 of infection, with accumulation of neutrophils 
and macrophages, and 4) resolution, which occurs after day 8 with presence of few 
macrophages & normalization of lung parenchyma. 
The pathology of pneumonia manifests as four general patterns which are lobar 
pneumonia, bronchopneumonia, interstitial pneumonia and milliary pneumonia. 
Lobar pneumonia classically involves an entire lung lobe relatively homogenously, 
although in some patients, a small portion of the lobe may be unaffected or at an 
earlier stage of involvement. 
Bronchopneumonia, a patchy consolidation involving one or several lobes, usually 
involves the dependent lower and the posterior portions of the lungs, a pattern that is 
attributable to the distribution of aspirated oropharyngeal content by gravity.  
Interstitial pneumonia predominantly involves the interstitium, including alveolar 
walls and the connective tissue around the bronchovascular tree. Milliary pneumonia 
resembles the millet seeds in milliary tuberculosis due to haematogenous spread. 
Persistent and uncontrolled infection may lead to several complications such as 
abscess formation, necrotizing pneumonia, vascular invasion with infarction, 
cavitation and extension to the pleura with effusion, empyema or bronchopleural 
fistula. (Marrie TJ et al, 2005). 
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1.7 Risk Factors for Community Acquired Pneumonia 
There are a lot of factors which increase the risk of developing CAP including 
extremes of age, immunosuppressive diseases (e.g. diabetes mellitus, neoplasms and 
HIV infection) respiratory disorders (e.g. bronchial asthma), use of drugs (e.g. oral 
steroids) and alcohol abusers. 
Age and co-morbidities are known to be the risk factors for CAP. They are supported 
by many findings in other countries: (Johnson PDR et al, 2002; Cunha BA et al, 
1998; Kaplan V et al, 2002) for example, studies at the University of Pittsburgh, 
USA, showed that the incidence rate of CAP rose five-fold as age increased from 65–
69 years to more than 90 years (Kaplan V et al, 2002) and, in the Spanish Evan-65 
study, the burden of CAP was found to increase with age. (Ochoa-Gonder O et al, 
1993).  
Aging is associated with a decline in lung performance due to increase in elastic 
recoil of the lung, chest wall compliance and respiratory muscle strength. The 
mucociliary clearance, cough reflex and oropharyngeal deglutition are also impaired 
in the elderly and the ability to mount an immune response is abnormal due to 
impairment of T-cell function. Oropharyngeal colonization rate with pathogens were 
also increased in the elderly. These abnormalities predispose to infection by 
microaspiration which is an important cause of pneumonia in the elderly. (Kikuchi et 
al, 1994) The presence of comorbidities and poor nutritional status in the elderly can 
lead to an increased susceptibility to infection. 
Other than that, heart failure, chronic obstructive pulmonary disease (COPD), and 
malignancies were the leading co-morbidities found in several studies for CAP 
previously (Godwin C Mbata et al, 2013; Ewig S et al, 2004; Menendez R et al, 
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2008). Studies have shown an increased rate of lower respiratory tract infections in 
patients with heart failure and, in fact, CAP is known to be an exacerbating factor in 
patients with congestive cardiac failure (Bonan JT et al, 1999; Thompson WW et al, 
2003). 
In a population based case-control study of risk factors for CAP of 74610 adults 
patient in Spain, previous respiratory infection and chronic bronchitis significantly 
increase risk of CAP (Admiral J, 1996). COPD is a known frequent co-morbidity in 
patients admitted to hospital for CAP and respiratory failure. While a study of severe 
CAP in 529 patients in 33 intensive care units in Spain found COPD to be the most 
frequent co-morbidity (Fine MJ et al, 1997; Godwin C Mbata et al, 2013). 
Not to forget, smoking is also one of the risk factors for getting the pneumonia. 
Smoking alters the mucociliary transport, epithelial cell function and increase risk of 
adhesion of certain pathogens such as S. pneumonia and H. influenza. A recent large 
population based study by Almirall J et al (2000) showed that, both current smokers 
and ex-smokers had a higher risk for CAP.  
Other than that, heavy alcohol use causes alterations of the immune system, impairs 
the function of lymphocytes, neutrophils and other inflammatory cells, increasing 
host susceptibility to infectious disease, especially bacterial pneumonia. 
 
1.8 Diagnosis Of Community Acquired Pneumonia 
For diagnosing CAP, patient may present with fever or hypothermia, rigors, sweating, 
new cough with or without sputum (or change in color), chest discomfort, pleuritic 
chest pain, chills, rigors and dyspnea. Most patients also have nonspeciﬁc symptoms, 
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such as fatigue, myalgias, abdominal pain, anorexia, nausea, vomiting, diarrhea, 
arthralgia and headache. The presentation can range from mild to fatal disease. The 
onset may be sudden or insidious.  
In the elderly, it is more common to be afebrile or hypothermic, and sometimes 
altered mental status is the only complaint. 
From clinical examination, the findings include tachypnea and dull to percussion over 
the lungs. The auscultatory ﬁndings consistent with pneumonia are such as altered 
breath sounds, increase vocal resonance, bronchial breath sounds, pleural friction rub 
and/ or localized rales. In severe cases, patients might be reduced in conscious level 
and have respiratory failure (British Thoracic Society, 2009). 
A diagnosis of pneumonia based on clinical features has a sensitivity of 47-69% and a 
specificity of 58-75% (Marrie TJ et al, 2005). 
 
1.9 Laboratory Investigations for Community Acquired Pneumonia (CAP) 
In investigating this disease, chest radiography is considered important for 
establishing the diagnosis of pneumonia and for distinguishing this condition from 
acute bronchitis, which is a common cause of antibiotic abuse. Other than that, it also 
can be used to detect associated lung diseases, to gain insight into the causative agent 
(in some cases), to assess severity, and as a baseline to assess response.  
Other than that, we also need sputum microscopy and culture. Sputum need to be 
collected in sterile screwed containers. Adequacy of sputum was defined as more than 
2ml of sputum containing of less than 15 epithelial cells on microscopy (Restrepo MI 
et al, 2006). A study by Niazlin et al in Kuala Lumpur (2012), showed that the 
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highest yield from the sputum culture were normal mouth flora (83%) followed by 
enterobacter spp., Group G streptococcus and Pseudomonas aeruginosa. 
Immunochromatography (ICT) method and molecular method such as polymerase 
chain reaction (PCR) improved the detection of S. pneumoniae in CAP patients as 
compared to conventional culture. 
Other laboratory values that should be determined for patients who are hospitalized 
are: complete blood cell count and differential, serum creatinine, blood urea nitrogen, 
glucose, electrolytes, and liver function tests.  
Besides that, oxygen saturation should be assessed. The BTS guidelines recommend 
arterial blood gas measurement only when the patient’s oxygen saturation is less than 
92% or other features of severe pneumonia are present (Macfarlane JT et al, 2001) or 
when there are  signs and symptoms suggestive of carbon dioxide retention.  
There should be two pretreatment blood cultures, as well as Gram staining and 
culture of expectorated sputum. Selected patients should have microbiological studies 
for tuberculosis and legionella infection.  
The rationale for performing microbiological studies is to establish an aetiologic 
diagnosis is based on attempts to improve care of the individual patient with 
pathogen-speciﬁc treatment; to improve care of other patients and to advance 
knowledge by detecting epidemiologically important organisms (Legionella 
pneumophila, penicillin-resistant Streptococcus pneumoniae, and methicillin-resistant 
Staphylococcus aureus); to implement contact tracing and antimicrobial prophylaxis 
in appropriate settings (such as cases of Neisseria meningitidis infection, 
Haemophilus inﬂuenzae type B infection, and tuberculosis); to prevent antibiotic 
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abuse as well as development of antibiotic resistance; and to reduce antibiotic 
expense because as we know, CAP is one of the major healthcare burdens.  
Currently, biomarkers have been increasingly proposed as useful tools in identifying 
patients with infection and guiding therapy. The two serum markers that have been 
most widely studied to prognosticate outcome are C-reactive protein (CRP) and 
procalcitonin (PCT). PCT, the precursor of calcitonin, arises in severe bacterial 
infection, but not in viral illness. However, this biomarker is not yet widely available 
and is expensive, and the added value of using PCT across inpatient populations has 
not yet been demonstrated. (Michael S et al, 2007; Christ-Crain M et al, 2006; Masia 
M et al, 2005) One study found that commonly measured and widely available 
inflammatory protein, CRP, improved the CURB-65 AUROC for 30 day mortality 
among CAP patients (Menendez R et al, 2009), but this requires validation in further 
study (Chalmers JD, 2012). 
 
1.10 Severity Score for  Community Acquired Pneumonia 
The most important step in management of CAP is the initial assessment of the 
severity of the disease. Assessment of severity of the disease in CAP is very 
important for further optimum care of the patient. An accurate assessment helps the 
clinician to determine the site of care, the extent of diagnostic testing and the type and 
intensity of treatment especially antibiotics of choice. (Capelastegui A. et al, 2006; 
Huang DT et al, 2008; Liapikau A et al, 2009; Myint PK et al, 2009). 
However, a number of studies suggest that routine clinical judgement is subjective 
and often not sufficient for assessing the severity of the CAP. Clinical judgement 
alone is prone to error in stratifying mortality risk and may underestimate its severity. 
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This may result in under treatment and poor outcomes. (Neil Am et al, 1996; Neill 
AM et al, 1996; Woodhead MA, 1987; Almirall J et al, 2000). 
Therefore  clinical prediction rules for CAP management offer a useful adjunct to the 
art of clinical practice. There are several pneumonia severity scoring systems that 
have been proposed as a tool for augmenting clinical judgement for stratifying 
patients with CAP into different management groups of patients for further active 
treatment and prevent insufficiently aggressive interventions for patients at high risk 
of complications. (Tang CM et al, 1993; Neil AM et al, 1996). 
Chun Shing Kwok et al (2013) already identified 20 different published risk 
prediction models for mortality in CAP. Four models relied on clinical variables that 
could be assessed in community settings. Nine models required laboratory tests in 
addition to clinical variables, and the best performance levels among the validated 
models were CURB and CURB-65. The PSI was the only validated model with good 
discriminative ability among the four that relied on clinical, laboratorial and 
radiological variables.  
However, there has yet to be a clear consensus on which model that should be used 
(Singanayam A et al, 2009). 
The severity scoring systems available are: 
1) BTS score (BTS and the public health lab service, 1987; Farr M et al, 1991),  
2) Mortality Risk Index (Leroy O et al, 1996), 
3) CURB (Neill AM et al, 1996),  
4) PSI (Fine MJ et al 1997),  
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5) CURB-65 ((Lim WS et al, 2003; Barlow G et al, 2007; Ewig S et al, 2004) 
6) CRB-65 (confusion, respiratory rate, blood pressure, age more than 65 years 
old) (Lim WS et al, 2003),  
7) Modified American Thoracic Society (ATS) Rule (Ewig S et al, 2004),  
8) SOAR (systolic blood pressure, oxygenation, age, respiratory rate) (Myint PK 
et al, 2006),  
9) CURB age (confusion, urea level, respiratory rate, blood pressure, age) (Myint 
PK et al, 2007),  
10) A-DROP [(i) Age (male > 70 years, female > 75 years); (ii) Dehydration 
(blood urea nitrogen (BUN) > 210 mg/L); (iii) Respiratory failure (SaO2 < 
90% or PaO2 < 60 mm Hg); (iv) Orientation disturbance (confusion); and (v) 
low blood Pressure (systolic blood pressure < 90 mm Hg)]. ) (Shindo Y et al, 
2008),  
11) CURSI (confusion, urea, respiratory rate and shock index) (Nullman et al, 
2014),  
12) CURASI (confusion, urea, respiratory rate and adjusted shock index) (Myint 
PK et al, 2009),  
13) PIRO score(predisposition, insult, response and organ dysfunction). This score 
including the presence of the following variables: comorbidities (chronic 
obstructive pulmonary disease, immunocompromise), age >70 years, 
multilobar opacities in chest radiograph,shock, severe hypoxemia,acute renal 
failure,bacteremia, acute respiratory distress syndrome. (Rello et al, 2009) 
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14) IDSA/ATS 2007 (American Thoracic Society/Infectious Disease Society of 
America 2007) (Lipikou A, 2009),  
15) PARBscore (presence of pleural effusions, albumin <3.0 g/dl, respiratory rate 
>30 breath /minute, blood urea level >25 mg/dl) (Uchiyama N et al, 2010),  
16) AFSS (Abbreviated Fine Score) (Escobar GJ et al, 2008),  
17) CARSI (confusion, age, respiratory rate and shock index) (Musonda P et al, 
2011) 
18) CARASI (confusion, age, respiratory rate and adjusted shock index) 
(MusondaP et al, 2011) 
19) SMART-COP. This criteria consists of low systolic blood pressure, multilobar 
chest radiography involvement, low albumin level, high respiratory rate, 
tachycardia, confusion, poor oxygenation and low arterial pH. 
20) SWAT-Bp. This criteria consists of male sex (S), wasting (W), non-ambulatory 
(A), Temperature of more than 38*C or less than 35*C (T) and blood pressure 
of less than 100/60 (Bp). Mortality for scores 0-5 was 0%, 3.3%, 7.4%, 29.2%, 
61.5% and 87.5% respectively (Edmund Birkhamshaw et al, 2013). 
Among these severity scores, the CURB-65 and PSI are two of the most prominent 
methods in regards of assessing the severity of community acquired pneumonia. (Lim 
WS, 2003; Moran GJ et al, 2009; ATS / IDSA, 2005; Mandell LA et al, 2007; 
Charles PG et al, 2008; Yu KT et al, 2008; Waterer GW et al, 2006). 
First, the CURB-65 score, a simple method of assessing and risk stratifying CAP 
patients, is composed of five separate criterias, namely, confusion, uremia (blood urea 
